SAGE Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

SAGE 169.46 +2.75 (1.65%)
price chart
Sage Therapeutics Inc. (SAGE) Soars 5.14% on December 27
Sage Therapeutics Inc. (SAGE) had a good day on the market for Wednesday December 27 as shares jumped 5.14% to close at $164.16.
Could Sage Therapeutics, Inc. (SAGE) Change Direction After Touching All ...  Frisco Fastball
0% Of Sage Therapeutics, Inc. (SAGE) Is Owned By Hedge Funds  Post Analyst
Sage Therapeutics Inc. (SAGE) Soars 5.17% on January 09
Sage Therapeutics Inc. (SAGE) had a good day on the market for Tuesday January 09 as shares jumped 5.17% to close at $171.01.
SAGE Therapeutics (NASDAQ:SAGE) Rating Reiterated by JPMorgan Chase & Co.
SAGE Therapeutics (NASDAQ:SAGE)'s stock had its “buy” rating restated by equities research analysts at JPMorgan Chase & Co.
SAGE Therapeutics (SAGE) Receives Buy Rating from JPMorgan Chase & Co.  The Lincolnian Online
Sage Therapeutics to Provide Pipeline Update at JP Morgan Healthcare ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that in a corporate presentation ...
A Comparison of Top Movers: The AES Corporation (AES), Sage Therapeutics ...  StockNewsGazette
Which Insiders Are Selling Sage Therapeutics, Inc. (SAGE)?  Economic News
Sage Therapeutics Inc. (SAGE) Soars 6.75% on December 25
Sage Therapeutics Inc. (SAGE) had a good day on the market for Monday December 25 as shares jumped 6.75% to close at $165.89.
Insider Selling: SAGE Therapeutics Inc (NASDAQ:SAGE) Insider Sells 44000 ...
SAGE Therapeutics logo SAGE Therapeutics Inc (NASDAQ:SAGE) insider Stephen Kanes sold 44,000 shares of the stock in a transaction dated Wednesday, January 10th.
Palo Alto Investors Has Cut Its Sage Therapeutics (SAGE) Holding by $15.24 ...  BZ Weekly
Zacks: Brokerages Anticipate SAGE Therapeutics Inc (SAGE) Will Announce ...  StockNewsTimes
Insider Selling: SAGE Therapeutics Inc (SAGE) CEO Sells 210247 Shares of Stock
SAGE Therapeutics logo SAGE Therapeutics Inc (NASDAQ:SAGE) CEO Jeffrey M. Jonas sold 210,247 shares of the firm's stock in a transaction that occurred on Thursday, December 21st.
Reaffirmed: SAGE Therapeutics (NASDAQ:SAGE) “Buy” Rating Maintained by BMO ...  KL Daily
BMO Capital Has Just Reaffirmed $80.0 Target Price Per Share on SAGE ...  Frisco Fastball
Rhenman & Partners Asset Management AB Buys ACADIA Pharmaceuticals Inc, Gilead ...
Stockholm, V7, based Investment company Rhenman & Partners Asset Management AB buys ACADIA Pharmaceuticals Inc, Gilead Sciences Inc, Sage Therapeutics Inc, AmerisourceBergen Corp, Flexion Therapeutics Inc, Jazz Pharmaceuticals PLC, Esperion ...
Should Investors Still Care About Sage Therapeutics, Inc. (SAGE), Cloudera ...
Sage Therapeutics, Inc. is maintained at an average outperform rating by 14 stock analysts, and there are at least 10.12% of shares outstanding that are currently legally short sold.
Sage Therapeutics, Inc. (SAGE)- Stocks Luring Investors Focus  NASDAQ Times
Wells Fargo & Company MN Has $6.48 Million Position in SAGE Therapeutics ...  Dispatch Tribunal
As Sage Therapeutics (Put) (SAGE) Stock Rose, Ghost Tree Capital Has Raised ...
Scott Ferguson decreased its stake in Autodesk Inc (ADSK) by 94.73% based on its latest 2017Q3 regulatory filing with the SEC.